Raymond Tzer Pin Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Raymond Tzer Pin Lin has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Marc Chavatte
National Public Health Laboratory, Communicable Diseases Agency, Singapore, Singapore
4 shared publications - Lisa Fong Poh Ng
A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
4 shared publications Douglas Chan
Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore, Singapore
3 shared publications- Ka Lip Chew
Department of Laboratory Medicine, National University Hospital, Singapore, Singapore
3 shared publications - Laurent Renia
Nanyang Technological University
3 shared publications Lin Cui
3 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (10)
Associations of age, COVID-19 vaccination, and SARS-CoV-2 infection history with health-related quality of life in a community-based longitudinal cohort in Singapore
- 9 September 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (10)
Open AccessAssociations of age, COVID-19 vaccination, and SARS-CoV-2 infection history with health-related quality of life in a community-based longitudinal cohort in Singapore
- Open Access
- 10 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e85608
Harnessing Participatory Surveillance Cohorts and Proxy Indicators to Dynamically Track Epidemic Trends and Undiagnosed COVID-19 Infections in Singapore: Longitudinal Observational Study
Background: Accurate COVID-19 incidence estimates, including undiagnosed cases, are vital for epidemic management but are often unavailable in real time. Participatory surveillance can capture community illness episodes; however, quantifying undiagnosed infections remains difficult. We assessed a Singaporean cohort to estimate medically unattended COVID-19 infections by combining symptom models with proxy epidemic indicators. Objective: This study aims to estimate COVID-19 incidence and medically attended fractions using participatory surveillance data and to evaluate the consistency of these estimates against independently derived serological measures of infection in a community cohort in Singapore. Methods: We analyzed 11 survey waves (September 2021 to November 2022) from the SOCRATEs (Strengthening Our Community’s Resilience Against Threats from Emerging Infections) community cohort (n=1899), spanning Delta and Omicron variant waves. Respondents reported recent illness, symptoms, health care use, and COVID-19 diagnoses. Multilevel logistic regression of medically attended episodes estimated the probability of COVID-19 in unattended episodes, incorporating symptoms and external indicators—wastewater viral-load index and health care staff surveillance. The estimates of total infections and medically attended fractions were validated against independent serological survey results. Results: Among 2284 illness episodes, 756 were diagnosed with COVID-19, of which 62.4% (472/756) were medically attended. Health care–seeking declined from 83.9% (26/31) of COVID-19 episodes early in 2022 to 55.3% (47/85) by late 2022. Regression models demonstrated strong associations between COVID-19 infection and key symptoms and epidemic activity indicators. Estimated total infections were substantially higher than notified cases, reaching 1.0 to 2.9 times the reported incidence across successive variant waves. Model-based estimates of medically attended fractions were broadly consistent with serological benchmarks. Incidence estimates closely matched serological estimates in earlier intervals, with slight overestimation in later periods due to reinfection. Conclusions: Participatory surveillance, when combined with probabilistic modeling and external indicators of epidemic activity, can generate robust estimates of infection incidence and health care use. Agreement with serological data supports the validity of this integrated framework, although discrepancies persist in later epidemic phases due to reinfection dynamics. This approach provides a scalable and timely complement to traditional and serological surveillance systems.
- 10 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e85608
Open AccessHarnessing Participatory Surveillance Cohorts and Proxy Indicators to Dynamically Track Epidemic Trends and Undiagnosed COVID-19 Infections in Singapore: Longitudinal Observational Study
Background: Accurate COVID-19 incidence estimates, including undiagnosed cases, are vital for epidemic management but are often unavailable in real time. Participatory surveillance can capture community illness episodes; however, quantifying undiagnosed infections remains difficult. We assessed a Singaporean cohort to estimate medically unattended COVID-19 infections by combining symptom models with proxy epidemic indicators. Objective: This study aims to estimate COVID-19 incidence and medically attended fractions using participatory surveillance data and to evaluate the consistency of these estimates against independently derived serological measures of infection in a community cohort in Singapore. Methods: We analyzed 11 survey waves (September 2021 to November 2022) from the SOCRATEs (Strengthening Our Community’s Resilience Against Threats from Emerging Infections) community cohort (n=1899), spanning Delta and Omicron variant waves. Respondents reported recent illness, symptoms, health care use, and COVID-19 diagnoses. Multilevel logistic regression of medically attended episodes estimated the probability of COVID-19 in unattended episodes, incorporating symptoms and external indicators—wastewater viral-load index and health care staff surveillance. The estimates of total infections and medically attended fractions were validated against independent serological survey results. Results: Among 2284 illness episodes, 756 were diagnosed with COVID-19, of which 62.4% (472/756) were medically attended. Health care–seeking declined from 83.9% (26/31) of COVID-19 episodes early in 2022 to 55.3% (47/85) by late 2022. Regression models demonstrated strong associations between COVID-19 infection and key symptoms and epidemic activity indicators. Estimated total infections were substantially higher than notified cases, reaching 1.0 to 2.9 times the reported incidence across successive variant waves. Model-based estimates of medically attended fractions were broadly consistent with serological benchmarks. Incidence estimates closely matched serological estimates in earlier intervals, with slight overestimation in later periods due to reinfection. Conclusions: Participatory surveillance, when combined with probabilistic modeling and external indicators of epidemic activity, can generate robust estimates of infection incidence and health care use. Agreement with serological data supports the validity of this integrated framework, although discrepancies persist in later epidemic phases due to reinfection dynamics. This approach provides a scalable and timely complement to traditional and serological surveillance systems.
- Open Access
- 28 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Plasmid dynamics driving carbapenemase gene dissemination in healthcare environments: a nationwide analysis of closed Enterobacterales genomes
Plasmid-mediated transmission can account for half of carbapenem-producing Enterobacterales (CPE) dissemination, underscoring the need to identify genetic determinants of plasmid persistence in the hospital setting. From 1,088 CPE isolates detected through nationwide surveillance in Singapore over five years, 1,115 closed carbapenemase-producing plasmids were identified and clustered, of which 92.5% (n = 1031) were grouped into 48 plasmid clusters (PCs). The most common plasmid genotypes were PC1 and PC2. Of 389 isolates carrying blaKPC-2-positive PC1 plasmids and 283 isolates carrying blaNDM-1-positive PC2 plasmids, 236 (60.7%) and 168 (59.4%) putatively acquired the carbapenemase gene via plasmid-mediated horizontal transmission, whereas 153 (39.3%) and 115 (40.6%) putatively acquired the carbapenemase gene via clonal lineage-dependent vertical transmission, respectively. Less abundant plasmids showed distinct inserted genomic regions encoding genes related to heavy metal and formaldehyde detoxification not found in predominant plasmids. Our data suggest that PC1 and PC2 genotypes are better adapted for stable propagation of blaKPC-2 and blaNDM-1, respectively, during inter-patient clonal spread and across multiple species (and sequence types) compared to other genetic settings. We propose that a crucial factor enabling evolutionarily successful carbapenemase plasmid genotypes to achieve hyperendemicity in the population is the maintenance of conserved genomes, thus minimizing fitness costs to their hosts.
- 28 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessPlasmid dynamics driving carbapenemase gene dissemination in healthcare environments: a nationwide analysis of closed Enterobacterales genomes
Plasmid-mediated transmission can account for half of carbapenem-producing Enterobacterales (CPE) dissemination, underscoring the need to identify genetic determinants of plasmid persistence in the hospital setting. From 1,088 CPE isolates detected through nationwide surveillance in Singapore over five years, 1,115 closed carbapenemase-producing plasmids were identified and clustered, of which 92.5% (n = 1031) were grouped into 48 plasmid clusters (PCs). The most common plasmid genotypes were PC1 and PC2. Of 389 isolates carrying blaKPC-2-positive PC1 plasmids and 283 isolates carrying blaNDM-1-positive PC2 plasmids, 236 (60.7%) and 168 (59.4%) putatively acquired the carbapenemase gene via plasmid-mediated horizontal transmission, whereas 153 (39.3%) and 115 (40.6%) putatively acquired the carbapenemase gene via clonal lineage-dependent vertical transmission, respectively. Less abundant plasmids showed distinct inserted genomic regions encoding genes related to heavy metal and formaldehyde detoxification not found in predominant plasmids. Our data suggest that PC1 and PC2 genotypes are better adapted for stable propagation of blaKPC-2 and blaNDM-1, respectively, during inter-patient clonal spread and across multiple species (and sequence types) compared to other genetic settings. We propose that a crucial factor enabling evolutionarily successful carbapenemase plasmid genotypes to achieve hyperendemicity in the population is the maintenance of conserved genomes, thus minimizing fitness costs to their hosts.
- Open Access
Vaccines in Dermatology—Present and Future: A Review
Dermatological vaccines have emerged as critical tools in preventing and managing a wide spectrum of skin conditions ranging from infectious diseases to malignancies. By synthesizing evidence from existing literature, this review aims to comprehensively evaluate the efficacy, safety, and immunogenicity of vaccines used in dermatology, including both approved vaccines and those currently being researched. Vaccines discussed in this paper include those targeting dermatoses and malignancies (e.g., acne vulgaris, atopic dermatitis, and melanoma); infectious diseases (e.g., human papillomavirus (HPV); varicella zoster virus (VZV); herpes zoster (HZ); warts; smallpox; mpox (monkeypox); hand, foot, and mouth disease (HFMD); candidiasis and Group B Streptococcus (GBS); and neglected tropical diseases (e.g., Buruli ulcer, leprosy, and leishmaniasis). Through this review, we aim to provide a detailed understanding of the role of vaccines in dermatology, identify knowledge gaps, and propose areas for future research.
Open AccessVaccines in Dermatology—Present and Future: A Review
Dermatological vaccines have emerged as critical tools in preventing and managing a wide spectrum of skin conditions ranging from infectious diseases to malignancies. By synthesizing evidence from existing literature, this review aims to comprehensively evaluate the efficacy, safety, and immunogenicity of vaccines used in dermatology, including both approved vaccines and those currently being researched. Vaccines discussed in this paper include those targeting dermatoses and malignancies (e.g., acne vulgaris, atopic dermatitis, and melanoma); infectious diseases (e.g., human papillomavirus (HPV); varicella zoster virus (VZV); herpes zoster (HZ); warts; smallpox; mpox (monkeypox); hand, foot, and mouth disease (HFMD); candidiasis and Group B Streptococcus (GBS); and neglected tropical diseases (e.g., Buruli ulcer, leprosy, and leishmaniasis). Through this review, we aim to provide a detailed understanding of the role of vaccines in dermatology, identify knowledge gaps, and propose areas for future research.
- Open Access
- 24 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (4) , eadr0162
Massively parallel barcode sequencing revealed the interchangeability of capsule transporters in Streptococcus pneumoniae
Multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) family transporters are essential in glycan synthesis, flipping lipid-linked precursors across cell membranes. Yet, how they select their substrates remains enigmatic. Here, we investigate the substrate specificity of the MOP transporters in the capsular polysaccharide (CPS) synthesis pathway in Streptococcus pneumoniae . These capsule flippases collectively transport more than 100 types of capsule precursors. To determine whether they can substitute for one another, we developed a high-throughput approach to systematically examine nearly 6000 combinations of flippases and substrates. CPS flippases fall into three groups: relaxed, type-specific, and strictly specific. Cargo size and CPS acetylation affect transport, and we isolated additional gain-of-function flippase variants that can substitute for the peptidoglycan flippase YtgP (MurJ). We also showed that combining flippase variants in a single cassette allows various CPS precursors to be flipped, which may aid glycoengineering. This study reveals that MOP flippases exhibit broad specificity, shaping the evolution of glycan synthesis.
- 24 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (4) , eadr0162
Open AccessMassively parallel barcode sequencing revealed the interchangeability of capsule transporters in Streptococcus pneumoniae
Multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) family transporters are essential in glycan synthesis, flipping lipid-linked precursors across cell membranes. Yet, how they select their substrates remains enigmatic. Here, we investigate the substrate specificity of the MOP transporters in the capsular polysaccharide (CPS) synthesis pathway in Streptococcus pneumoniae . These capsule flippases collectively transport more than 100 types of capsule precursors. To determine whether they can substitute for one another, we developed a high-throughput approach to systematically examine nearly 6000 combinations of flippases and substrates. CPS flippases fall into three groups: relaxed, type-specific, and strictly specific. Cargo size and CPS acetylation affect transport, and we isolated additional gain-of-function flippase variants that can substitute for the peptidoglycan flippase YtgP (MurJ). We also showed that combining flippase variants in a single cassette allows various CPS precursors to be flipped, which may aid glycoengineering. This study reveals that MOP flippases exhibit broad specificity, shaping the evolution of glycan synthesis.
- Top Cited PapersOpen Access
- 16 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Global disparities in SARS-CoV-2 genomic surveillance
Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness, and efforts must be made to support low- and middle-income countries improve their local sequencing capacity.
- 16 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Top Cited PapersOpen AccessGlobal disparities in SARS-CoV-2 genomic surveillance
Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness, and efforts must be made to support low- and middle-income countries improve their local sequencing capacity.
- Top Cited PapersOpen Access
- 26 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 377 (6609) , 960-966
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
Understanding the circumstances that lead to pandemics is important for their prevention. We analyzed the genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the coronavirus disease 2019 (COVID-19) pandemic. We show that SARS-CoV-2 genomic diversity before February 2020 likely comprised only two distinct viral lineages, denoted “A” and “B.” Phylodynamic rooting methods, coupled with epidemic simulations, reveal that these lineages were most probably the result of at least two separate cross-species transmission events into humans. The first zoonotic transmission likely involved lineage B viruses around 18 November 2019 (23 October to 8 December), and the separate introduction of lineage A likely occurred within weeks of this event. These findings indicate that it is unlikely that SARS-CoV-2 circulated widely in humans before November 2019 and define the narrow window between when SARS-CoV-2 first jumped into humans and when the first cases of COVID-19 were reported. As with other coronaviruses, SARS-CoV-2 emergence likely resulted from multiple zoonotic events.
- 26 August 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 377 (6609) , 960-966
Top Cited PapersOpen AccessThe molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
Understanding the circumstances that lead to pandemics is important for their prevention. We analyzed the genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the coronavirus disease 2019 (COVID-19) pandemic. We show that SARS-CoV-2 genomic diversity before February 2020 likely comprised only two distinct viral lineages, denoted “A” and “B.” Phylodynamic rooting methods, coupled with epidemic simulations, reveal that these lineages were most probably the result of at least two separate cross-species transmission events into humans. The first zoonotic transmission likely involved lineage B viruses around 18 November 2019 (23 October to 8 December), and the separate introduction of lineage A likely occurred within weeks of this event. These findings indicate that it is unlikely that SARS-CoV-2 circulated widely in humans before November 2019 and define the narrow window between when SARS-CoV-2 first jumped into humans and when the first cases of COVID-19 were reported. As with other coronaviruses, SARS-CoV-2 emergence likely resulted from multiple zoonotic events.
- Open Access
- 8 August 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Understanding the impact of age on vaccinations is essential for the design and delivery of vaccines against SARS-CoV-2. Here, we present findings from a comprehensive analysis of multiple compartments of the memory immune response in 312 individuals vaccinated with the BNT162b2 SARS-CoV-2 mRNA vaccine. Two vaccine doses induce high antibody and T cell responses in most individuals. However, antibody recognition of the Spike protein of the Delta and Omicron variants is less efficient than that of the ancestral Wuhan strain. Age-stratified analyses identify a group of low antibody responders where individuals ≥60 years are overrepresented. Waning of the antibody and cellular responses is observed in 30% of the vaccinees after 6 months. However, age does not influence the waning of these responses. Taken together, while individuals ≥60 years old take longer to acquire vaccine-induced immunity, they develop more sustained acquired immunity at 6 months post-vaccination. A third dose strongly boosts the low antibody responses in the older individuals against the ancestral Wuhan strain, Delta and Omicron variants.
- 8 August 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Open AccessLower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Understanding the impact of age on vaccinations is essential for the design and delivery of vaccines against SARS-CoV-2. Here, we present findings from a comprehensive analysis of multiple compartments of the memory immune response in 312 individuals vaccinated with the BNT162b2 SARS-CoV-2 mRNA vaccine. Two vaccine doses induce high antibody and T cell responses in most individuals. However, antibody recognition of the Spike protein of the Delta and Omicron variants is less efficient than that of the ancestral Wuhan strain. Age-stratified analyses identify a group of low antibody responders where individuals ≥60 years are overrepresented. Waning of the antibody and cellular responses is observed in 30% of the vaccinees after 6 months. However, age does not influence the waning of these responses. Taken together, while individuals ≥60 years old take longer to acquire vaccine-induced immunity, they develop more sustained acquired immunity at 6 months post-vaccination. A third dose strongly boosts the low antibody responses in the older individuals against the ancestral Wuhan strain, Delta and Omicron variants.